loader

heart disease

LATEST ARTICLES
OTC:CRTPF
cannabis investing

Cardiol Therapeutics Announces Study Results Confirm the Cardioprotective Role of its Pharmaceutical Cannabidiol Formulation in a Model of Heart Failure

OTC:CRTPF
cannabis investing

Cardiol Therapeutics Announces Filing of 2019 Year-End Financial Statements and MD&A

OTC:CRTPF
cannabis investing

Cardiol Therapeutics Signs Supplier Agreement with Medical Cannabis by Shoppers, a Subsidiary of Shoppers Drug Mart Inc.

OTC:CRTPF
cannabis investing

Cardiol Therapeutics Receives Health Canada Approval for Phase 1 Study of its Pharmaceutically Produced Cannabidiol (CBD) Formulation

OTC:CRTPF
cannabis investing

Cardiol Therapeutics’ Exclusive Manufacturing Partner Receives Three-Year Renewal and Amendment of its Cannabis Act License from Health Canada

OTC:CRTPF
cannabis investing

Cardiol Therapeutics Appoints Michael J. Willner, Esq. as Business Advisor

Cardiol Therapeutics Appoints Former GW Pharmaceuticals Executive Colin Stott to Its Board of Directors
cannabis investing

Cardiol Therapeutics Appoints Former GW Pharmaceuticals Executive Colin Stott to Its Board of Directors

Cardiol Therapeutics Comments on the Descheduling of Purisys Cannabinoid Ingredients by U.S. Drug Enforcement Agency
cannabis investing

Cardiol Therapeutics Comments on the Descheduling of Purisys Cannabinoid Ingredients by U.S. Drug Enforcement Agency

OTC:CRTPF
cannabis investing

Cardiol Therapeutics Announces Clinical Steering Committee for Phase 2 International Trial in Acute Myocarditis Using CardiolRx(TM) 100

OTC:CRTPF
cannabis investing

Cardiol Therapeutics Announces Completion of Manufacturing Scale-up for Commercialization of CardiolRx(TM)100

OTC:CRTPF
pharmaceutical investing

Cardiol Therapeutics to Webcast Live at VirtualInvestorConferences.com on September 12th

Latest News

More News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES